• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Illumina, Mayo Clinic partner on bioinformatics for genetic disorder testing

Illumina, Mayo Clinic partner on bioinformatics for genetic disorder testing

November 11, 2016
CenterWatch Staff

Illumina has entered an agreement with Mayo Clinic to make advancements in next-generation sequencing technology with the intent to accelerate Mayo’s delivery of genetic and genomic expertise.

Together, the organizations plan to integrate existing services and software tools and employ new, innovative solutions to improve Mayo Clinic’s reporting workflows for researching inherited disease, enabling Illumina to develop an informatics platform and knowledge base that can improve and automate genomic interpretation.

As part of the agreement, Mayo Clinic will implement BaseSpace Clarity LIMS in specific laboratories to provide testing of the tool. BaseSpace Clarity LIMS is a system to provide comprehensive workflow tracking and integration in laboratories. Mayo Clinic will also deploy and provide feedback on its use of BaseSpace Sequence Hub, a cloud-based genomics computing environment for data analysis and management, and BaseSpace Variant Interpreter, a cloud-based interpretation and reporting platform designed to decrease the time and effort required to assess biological insight from genomic data. The software solutions will be piloted by Mayo Clinic to annotate and interpret genetic variants with regard to their potential role in the development and progression of diseases.

“Through this relationship, we will be able to generate large volumes of genomic information, interrogate the data, and then compare it to what’s known about those variants and those genetic aberrations in real time, saving our geneticists time,” said William Morice, II, M.D., Ph.D., chair of Mayo’s Department of Laboratory Medicine and Pathology and president of Mayo Medical Laboratories. “We are pleased to work with Illumina and to leverage each other’s expertise in genetic sequencing and analysis.”

“Mayo Clinic has been at the forefront of advanced medical research and patient care for a long time,” said Sanjay Chikarmane, senior vice president and general manager of Illumina Enterprise Informatics. “BaseSpace Informatics Suite has the ability to provide a cloud-based software solution that can manage, analyze and interpret data automatically. We’re pleased that our offering will help Mayo Clinic make sense of genomic data faster and more accurately.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing